Modified skin window technique for the extended characterisation of acute inflammation in humans

Inflammation Research

Volumn 56, Issue 4, 2007, Pages 168-174

  Marks, D J B ^a   Radulovic, M ^a   McCartney, S ^b   Bloom, S ^b   Segal, A W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Human inflammation models; IBD; Inflammatory mediators; Intracellular signalling; Skin inflammation and models

Indexed keywords

DNA; IMMUNOMODULATING AGENT; INTERLEUKIN 8; MURAMYL DIPEPTIDE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; RNA; SODIUM CHLORIDE; TRANSCRIPTION FACTOR; IMMUNOLOGIC FACTOR; IMMUNOLOGICAL ADJUVANT; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOLOGICAL PROCEDURES; INFLAMMATION; LEUKOCYTE; MICROSCOPY; NEUTROPHIL; NORMAL HUMAN; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SKIN ABRASION; ACUTE DISEASE; CASE CONTROL STUDY; CELL MOTION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SKIN;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; CASE-CONTROL STUDIES; CELL MOVEMENT; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERLEUKIN-8; LEUKOCYTES; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN WINDOW TECHNIQUE; TRANSCRIPTION FACTORS;

EID: 34447621954     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6119-6     Document Type: Article

References (42)

1. Ben Baruch A, Michiel DF, Oppenheim JJ. Signals and receptors involved in recruitment of inflammatory cells. J Biol Chem 1995; 270: 11703-6.
2. Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004; 25: 75-84.
3. Segal AW, Loewi G. Neutrophil dysfunction in Crohn's disease. Lancet 1976; 2: 219-21.
4. Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182: 526-33.
5. Gallin JI, Buescher ES. Abnormal regulation of inflammatory skin responses in male patients with chronic granulomatous disease. Inflammation 1983; 7: 227-32.
6. Passero FC, Myers AR. Decreased numbers of monocytes in inflammatory exudates in systemic lupus erythematosus. J Rheumatol 1981; 8: 62-8.
7. Rebuck JW, Crowley JH. A method of studying leukocytic functions in vivo. Ann NY Acad Sci 1955; 59: 757-805.
8. Senn H, Holland JF, Banerjee T. Kinetic and comparative studies on localized leukocyte mobilization in normal man. J Lab Clin Med 1969; 74: 742-56.
9. Mass MF, Dean PB, Weston WL, Humbert JR. Leukocyte migration in vivo: a new method of study. J Lab Clin Med 1975; 86: 1040-6.
10. MacPhee MJ, Rode H, Broadhead M, Christou NV, Meakins JL, Gordon J. Skin window chambers, a novel method for recovering the cells involved in delayed-type hypersensitivity. J Immunol Methods 1987; 103: 267-73.
11. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968; 50: 129-37.
12. Day RM, Harbord M, Forbes A, Segal AW. Cantharidin blisters: a technique for investigating leukocyte trafficking and cytokine production at sites of inflammation in humans. J Immunol Methods 2001; 257: 213-20.
13. Honkanen RE. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A. FEBS Lett 1993; 330: 283-6.
14. Zimmerli W, Gallin JI. Monocytes accumulate on Rebuck skin window coverslips but not in skin chamber fluid. A comparative evaluation of two in vivo migration models. J Immunol Methods 1987; 96: 11-7.
15. Addison IE, Johnson B, Shaw M. A human skin window technique using micropore membranes. J Immunol Methods 1982; 54: 129-39.
16. Marks DJ, Harbord MW, MacAllister R, Rahman FZ, Young J, Al Lazikani B et al. Defective acute inflammation in Crohn's disease: a clinical investigation. Lancet 2006; 367: 668-78.
17. Willment JA, Marshall AS, Reid DM, Williams DL, Wong SY, Gordon S et al. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur J Immunol 2005; 35: 1539-47.
18. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980; 1: 514.
19. Shimizu S, Yasui K, Tani Y, Yamada H. Acyl-CoA oxidase from Candida tropicalis. Biochem Biophys Res Commun 1979; 91: 108-13.
20. Reeves EP, Lu H, Jacobs HL, Messina CG, Bolsover S, Gabella G et al. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002; 416: 291-7.
21. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11: 1475-89.
22. Burger R, Zilow G, Bader A, Friedlein A, Naser W. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. J Immunol 1988; 141: 553-8.
23. Azuma I, Seya T. Development of immunoadjuvants for immunotherapy of cancer. Int Immunopharmacol 2001; 1: 1249-59.
24. Li J, Moran T, Swanson E, Julian C, Harris J, Bonen DK et al. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Hum Mol Genet 2004; 13: 1715-25.
25. Segal AW. How neutrophils kill microbes. Annu Rev Immunol 2005; 23: 197-223.
26. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. 1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83: 865-75.
27. Segal AW, Fortunato A, Herd T. A rapid single centrifugation step method for the separation of erythrocytes, granulocytes and mononuclear cells on continuous density gradients of Percoll. J Immunol Methods 1980; 32: 209-14.
28. Lea T, Vartdal F, Nustad K, Funderud S, Berge A, Ellingsen T et al. Monosized, magnetic polymer particles: their use in separation of cells and subcellular components, and in the study of lymphocyte function in vitro. J Mol Recognit 1988; 1: 9-18.
29. Corradi A, Franzi AT, Rubartelli A. Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes. Exp Cell Res 1995; 217: 355-62.
30. Kollisch G, Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005; 114: 531-41.
31. Cho J. Update on inflammatory bowel disease genetics. Curr Gastroenterol Rep 2000; 2: 434-9.
32. Auer J, Weber T, Berent R, Lassnig E, Lamm G, Eber B. Genetic polymorphisms in cytokine and adhesion molecule genes in coronary artery disease. Am J Pharmacogenomics 2003; 3: 317-28.
33. Imahara SD, O'Keefe GE. Genetic determinants of the inflammatory response. Curr Opin Crit Care 2004; 10: 318-24.
34. Jin P, Panelli MC, Marincola FM, Wang E. Cytokine polymorphism and its possible impact on cancer. Immunol Res 2004; 30: 181-90.
35. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 1998; 12: 502-13.
36. Cantrell D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin Immunol 2002; 14: 19-26.
37. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-68.
38. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005; 6: 322-7.
39. Sachs AB, Varani G. Eukaryotic translation initiation: there are (at least) two sides to every story. Nat Struct Biol 2000; 7: 356-61.
40. Poole AW, Pula G, Hers I, Crosby D, Jones ML. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol Sci 2004; 25: 528-35.
41. Pullen N, Thomas G. The modular phosphorylation and activation of p70s6k. FEBS Lett 1997; 410: 78-82.
42. Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel disease: mechanisms and possible novel therapies for chronic inflammation. J Clin Invest 2001; 108: 523-6.